ARCHIVES

Zaltrap Receives Positive Opinion For European Market From CHMP

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

NCI Resources, Services Available For Cancer Research

June 7, 1996

100 NSABP Sites May Enroll Patients; Only One Trial Open

July 15, 1994